These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1937998

  • 1. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD, Candito M, Ferrari E, Jacomet Y, Morand P, Lapalus P.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
    Fogari R, Poletti L, Tettamanti F, Cesana B, Savonitto S.
    G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158
    [Abstract] [Full Text] [Related]

  • 3. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
    Soberman J, Greenberg S, Frishman W.
    J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
    [Abstract] [Full Text] [Related]

  • 4. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ, Smith L, Glover DR.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [Abstract] [Full Text] [Related]

  • 5. Dilevalol: a dose-response study in normal volunteers.
    Walden RJ, Graham BR, Liu JB, Prichard BN.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():69-75. PubMed ID: 2196371
    [Abstract] [Full Text] [Related]

  • 6. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 9. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
    Wallin JD, Cook ME, Fletcher E, Holtzman JL, Winer N, Gavras H, Grim CE, Ramanathan KB, Vidt DG, Johnson BF.
    Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension].
    Bochicchio T, Pérez-Grovas HA, Carrizosa J, Herrera-Acosta J.
    Arch Inst Cardiol Mex; 1989 Dec; 59(2):181-6. PubMed ID: 2569857
    [Abstract] [Full Text] [Related]

  • 11. Influence of beta-blockade on circulating plasma levels of 3-methoxy-4-hydroxy phenylethylene glycol (MHPG) during exercise in moderate hypertension.
    Drici MD, Roux M, Candito M, Rimailho A, Morand P, Lapalus P.
    Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):807-11. PubMed ID: 1686746
    [Abstract] [Full Text] [Related]

  • 12. Intravenous dilevalol in the treatment of severe hypertension.
    Bursztyn M, Gavras I, Blasucci DJ, Gavras H.
    J Cardiovasc Pharmacol; 1989 May; 13(5):799-802. PubMed ID: 2472530
    [Abstract] [Full Text] [Related]

  • 13. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG, Mainka W, Schillings W, Knigge H, Montiel J, Fallois J, Agrawal R, Schramm T, Graf C, Giannetti BM, Bjarnason-Wehrens B, Prinz U, Rost RE.
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [Abstract] [Full Text] [Related]

  • 14. The pharmacodynamics of dilevalol.
    Riddell JG.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
    [Abstract] [Full Text] [Related]

  • 15. Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatment.
    Sbirrazzuoli V, Drici M, Garraffo R, Candito M, Gibelin P, Morand P, Lapalus P.
    Drugs Exp Clin Res; 1989 Jun; 15(5):223-9. PubMed ID: 2551622
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S, Di Pasquale P, Parrinello G, Tuttolomondo A, Follone G, Cardinale A, Ortoleva A, Giambanco F, Abruzzese G, Colomba D, Bologna P, Fernández P, Giubilato A, Valdes L, Albano V, Licata G.
    Drugs Exp Clin Res; 2000 Jun; 26(4):125-31. PubMed ID: 11109512
    [Abstract] [Full Text] [Related]

  • 17. Haemodynamic effects of long-term oral labetalol.
    Edwards RC, Raftery EB.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [Abstract] [Full Text] [Related]

  • 18. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 19. Effects of dilevalol in hypertension assessed by digital pulse plethysmography.
    Takemiya T, Shimizu M, Yamaguti S, Sugishita H, Miuria Y, Yamauti T.
    Clin Ther; 1992 Nov; 14(3):385-9. PubMed ID: 1638579
    [Abstract] [Full Text] [Related]

  • 20. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
    Walley T, Tsao Y, Scott A, Mackay E, Vandenburg M, Breckenridge A.
    Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.